,
2 min read
The regulatory landscape for pharmaceutical submissions in Europe is evolving rapidly. A major milestone in this transformation is the European Medicines Agency’s (EMA) decision to mandate the use of the PLM web-based eAF for Centrally Authorised Products (CAPs) starting 1 September 2026.
This shift is more than a procedural update—it reflects a broader move toward regulatory submissions, driven by digital and data-centric processes. As regulatory submissions become more structured and technology-driven, organizations must adapt quickly to remain compliant and competitive.
What Is the PLM Web-Based eAF?
The electronic Application Form (eAF) is a standardized digital form used for submissions across the EU. The PLM web-based eAF replaces traditional formats with structured, machine-readable data.
Unlike older systems, the PLM web-based eAF enables:
- Real-time validation
- Integration with EMA systems
- Structured data capture
- Improved submission accuracy
This supports digital regulatory transformation and aligns with the shift toward structured data submissions, improving efficiency and reducing manual errors.
Why Is This Change Being Introduced?
The move to mandatory adoption is driven by modernization and operational efficiency.
1. Improved Processing Speed and Accuracy
Automated workflows reduce manual effort and enhance regulatory compliance, which is critical for regulatory submissions.
2. System Integration
The PLM web-based eAF integrates with PMS and OMS, ensuring consistency across EMA submissions.
3. Reduced Submission Rejections
Structured formats minimize validation failures common with PDFs, supporting smoother CAP submissions.
4. Support for Digital Transformation
This initiative is part of a broader shift toward pharmaceutical regulatory updates and data-driven decision-making.
What Happens After 1 September 2026?
From this date, all CAP variation submissions must use the PLM web-based eAF.
Failure to comply may result in:
- Submission delays
- Increased rework
- Non-compliance risks
This makes early preparation essential for successful regulatory submissions, especially as expectations continue to evolve.
Are There Any Exceptions?
Limited exceptions exist, such as:
- System performance issues
- Data inconsistencies
- Temporary technical constraints
However, these are short-term and not reliable for long-term EMA submissions strategy under regulatory submissions requirements.
How Should Companies Prepare?
- Ensure Data Readiness: High-quality data is critical for structured data submissions and effective use of the PLM web-based eAF.
- Enable System Access: Ensure all stakeholders can access the PLM portal.
- Train Regulatory Teams: Build familiarity with workflows to support regulatory compliance.
- Test Early: Identify gaps before deadlines impact CAP submissions.
- Align Internal Processes: Update SOPs to match digital regulatory transformation goals and support regulatory submissions 2026.
Impact on Regulatory Strategy
- Shift Toward Structured Content: The industry is moving toward reusable, structured data, improving lifecycle management through the PLM web-based eAF.
- Increased Focus on Data Governance: Accurate data is critical for successful EMA submissions.
- Need for Automation: Automation tools are becoming essential for handling pharmaceutical regulatory updates
Key Challenges to Anticipate
Organizations may face:
- Data inconsistencies
- Limited PLM experience
- Integration gaps
- Resource constraints
Addressing these early ensures smoother regulatory submissions and better adoption of the PLM web-based eAF.
Conclusion
The EMA’s mandate for the PLM web-based eAF marks a major step toward a more digital regulatory ecosystem.
By 1 September 2026, organizations must fully transition to structured systems for regulatory submissions. As regulatory submissions continue to evolve, companies that invest in data quality, training, and system readiness will be better positioned to maintain compliance and efficiency.
This is not just a compliance requirement—it is a strategic opportunity to advance digital regulatory transformation and future-proof submission processes using the PLM web-based eAF.
